SLC5A2 and hypertensive disorder: Thus, information on comorbidities, such as hypertension or diabetes (no glucosuria at the time of measurement) or medication, that may affect renal function (e.g., RAS inhibitors, diuretics, or SGLT2 inhibitors) is missing and patients with stable but impaired eGFR may also be present in the data set despite inconspicuous urinalysis.